Building Communities of Practice for Sustainable Change

Name: Early Alzheimer Disease Detection through a Davos Initiative: Building Communities of Practice for Sustainable Change
Uploaded: 2026-06-22T04:00:00+00:00
Duration: 8 min 10 s
Description: In this episode, Elyse Perweiler, RN, MPP, Professor, Rowan–Virtua School of Osteopathic Medicine, Stratford, NJ, and Tim MacLeod, PhD, Executive Director,

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Subcutaneous Lecanemab for Early Alzheimer Disease: Evidence, Safety, and Patient Selection
Subcutaneous Lecanemab for Early Alzheimer Disease: Evidence, Safety, and Patient Selection
Alzheimer Disease & Dementias
Subcutaneous Lecanemab for Early Alzheimer Disease: Evidence, Safety, and Patient Selection
Michael Irizarry, MD, MPH
Michael Irizarry, MD, MPH
Clinical Biomarker Testing for Alzheimer Disease Pathology in the Context of Amyloid-Targeting Treatments
Clinical Biomarker Testing for Alzheimer Disease Pathology in the Context of Amyloid-Targeting Treatments
Alzheimer Disease & Dementias
Clinical Biomarker Testing for Alzheimer Disease Pathology in the Context of Amyloid-Targeting Treatments
Anna Hofmann, MD; Suzanne E. Schindler, MD, PhD
Anna Hofmann, MD; Suzanne E. Schindler, MD, PhD
Building Confidence in Alzheimer Disease Care: Real-World Communication Strategies
Building Confidence in Alzheimer Disease Care: Real-World Communication Strategies
Alzheimer Disease & Dementias
Building Confidence in Alzheimer Disease Care: Real-World Communication Strategies
Jeongyeon Hwang, MD; Samuel Gandy, MD
Jeongyeon Hwang, MD; Samuel Gandy, MD
Alzheimer Disease: Real-World Approaches to Patient Care
Alzheimer Disease: Real-World Approaches to Patient Care
Alzheimer Disease & Dementias
Alzheimer Disease: Real-World Approaches to Patient Care
Gregory E. Cooper, MD, PhD, FAAN
Gregory E. Cooper, MD, PhD, FAAN